BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 19089815)

  • 1. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage.
    Komaniwa S; Hayashi H; Kawamoto H; Sato SB; Ikawa T; Katsura Y; Udaka K
    Eur J Immunol; 2009 Jan; 39(1):96-112. PubMed ID: 19089815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CD8 alpha' in the CD4 versus CD8 lineage choice.
    Salmon P; Mong M; Kang XJ; Cado D; Robey E
    J Immunol; 1999 Nov; 163(10):5312-8. PubMed ID: 10553054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th cells and Th2 responses can develop in the absence of MHC class II-CD4 interactions.
    Wack A; Corbella P; Harker N; Roderick K; Norton T; Williams K; Williams O; Kioussis D
    J Immunol; 1999 Aug; 163(3):1162-9. PubMed ID: 10415010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathymic T cell receptor (TcR) targeting in mice lacking CD4 or major histocompatibility complex (MHC) class II: rescue of CD4 T cell lineage without co-engagement of TcR/CD4 by MHC class II.
    Müller KP; Kyewski BA
    Eur J Immunol; 1995 Apr; 25(4):896-902. PubMed ID: 7737291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II molecules are required for initiation of positive selection but not during terminal differentiation of human CD4 single positive thymocytes.
    Vanhecke D; Verhasselt B; De Smedt M; De Paepe B; Leclercq G; Plum J; Vandekerckhove B
    J Immunol; 1997 Apr; 158(8):3730-7. PubMed ID: 9103437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells.
    Bosselut R; Guinter TI; Sharrow SO; Singer A
    J Exp Med; 2003 Jun; 197(12):1709-19. PubMed ID: 12810689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the thymic environment on the CD4-versus-CD8 T lineage decision.
    Canelles M; Park ML; Schwartz OM; Fowlkes BJ
    Nat Immunol; 2003 Aug; 4(8):756-64. PubMed ID: 12858172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8/CD4 lineage commitment occurs by an instructional/default process followed by positive selection.
    Benveniste P; Knowles G; Cohen A
    Eur J Immunol; 1996 Feb; 26(2):461-71. PubMed ID: 8617319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different roles of MHC class recognition in thymocyte CD4 versus CD8 lineage commitment and positive selection.
    van Meerwijk JP; Germain RN
    Semin Immunol; 1994 Aug; 6(4):231-9. PubMed ID: 8000032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
    Yelon D; Schaefer KL; Berg LJ
    J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4/CD8 lineage commitment in T cell receptor transgenic mice: evidence for precommitment of CD4+ CD8+ thymocytes.
    Crompton T; Hefti H; Lees RK; Pircher H; MacDonald HR
    Semin Immunol; 1994 Aug; 6(4):249-56. PubMed ID: 8000034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
    He X; He X; Dave VP; Zhang Y; Hua X; Nicolas E; Xu W; Roe BA; Kappes DJ
    Nature; 2005 Feb; 433(7028):826-33. PubMed ID: 15729333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population.
    Li W; Kim MG; Gourley TS; McCarthy BP; Sant'Angelo DB; Chang CH
    Immunity; 2005 Oct; 23(4):375-86. PubMed ID: 16226503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR7 expression in developing thymocytes is linked to the CD4 versus CD8 lineage decision.
    Yin X; Ladi E; Chan SW; Li O; Killeen N; Kappes DJ; Robey EA
    J Immunol; 2007 Dec; 179(11):7358-64. PubMed ID: 18025179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a developmentally regulated phase of postselection expansion driven by thymic epithelium.
    Hare KJ; Wilkinson RW; Jenkinson EJ; Anderson G
    J Immunol; 1998 Apr; 160(8):3666-72. PubMed ID: 9558066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.